Tamoxifen is a hormonal therapy drug used to treat breast cancer, womb cancer and sometimes other cancers and conditions. It is best to read this information with our general information about hormonal therapies and the type of cancer you have. Like all cancer drugs, tamoxifen can cause side effects. Your cancer doctor, nurse, or pharmacist will tell you how often you will have it. Some of the side effects can be serious, so it is important to read the detailed information below. Your healthcare team can give you advice on how to manage any side effects. Tell your doctor or nurse straight away if you feel unwell or have severe side effects, including any we do not mention here. Your cancer doctor or nurse can explain the risk of these side effects to you. If you need medical attention for any reason other than cancer, always tell the healthcare staff that you are having this treatment. Tamoxifen can be given alone or with other types of treatment. Find out what tamoxifen is, how you have it and other important information about taking tamoxifen for breast cancer. Tamoxifen lowers the risk of early breast cancer coming back (recurring) after surgery or developing in the other breast. It can also control advanced breast cancer for some time. The liquid version of tamoxifen is called Saltamox. Whether you have a full or empty stomach can affect how much of a drug gets into your bloodstream. Never stop taking a cancer drug without talking to your specialist first. If you accidentally take more tamoxifen than you should, let your doctor or nurse know straight away. If you forget to take a dose, take the dose as soon as you remember, unless it is nearly time for your next dose. You have blood tests before and during your treatment. Don't take a double dose to make up for a forgotten dose. They check your levels of blood cells and other substances in the blood. Does propranolol cause depression Cheap viagra overnight How does tamoxifen affect breast cancer?Tamoxifen should be prescribed only for women at high risk for breast cancer and after a complete medical evaluation of a woman's individual risk factors. While tamoxifen fights estrogen in breast cancer cells, it also mimics the positive effects ofTamoxifen has been shown to be more beneficial for women whose breast cancer cells contain. Taking adjuvant tamoxifen for 10 years after primary treatment leads to a greater reduction in breast cancer recurrences and deaths than taking the drug. This content has not been reviewed within the past year and may not represent Web MD's most up-to-date information. To find the most current information, please enter your topic of interest into our search box. 14, 2007 (San Antonio) -- Even after treatment ends, Arimidex beats out tamoxifen in preventing breast cancer recurrence in women with hormone-fueled tumors. Updated results from this landmark trial also show that the increased risk of fractures associated with Arimidex therapy disappears after treatment stops. In the study, more than 5,000 women with hormone-receptor-positive tumors were followed for more than three years after treatment was stopped. The researchers show that an additional 25% of recurrences were prevented by Arimidex, compared with tamoxifen, says John F. Forbes, MD, professor of surgery at the University of Newcastle in Australia. During treatment, nearly 3% of women taking Arimidex had bone fractures vs. More than three years after treatment ended, the percentage was about 1.5% in both groups. Metastatic breast cancer in women and men: 20 to 40 mg orally daily for 5 years; doses greater than 20 mg should be given in divided doses (morning and evening) DCIS following breast surgery and radiation: 20 mg orally daily for 5 years To reduce the incidence of breast cancer in women at high risk for breast cancer: 20 mg orally daily for 5 years Comments: -There are no data to support the use of this drug other than for 5 years. Uses: -Metastatic For metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, this drug is an alternative to oophorectomy or ovarian irradiation. Patients whose tumors are estrogen receptor positive are more likely to benefit. -Ductal Carcinoma in Situ (DCIS): In women with DCIS, following breast surgery and radiation, to reduce the risk of invasive breast cancer. -Reduction in Breast Cancer Incidence in High Risk Women: To reduce the incidence of breast cancer in women at high risk. "High risk" is defined as women at least 35 years of age with a 5-year predicted risk of breast cancer greater than or equal to 1.67%, as calculated by the Gail Model. Tamoxifen breast cancer Male Breast Cancer Tamoxifen CancerCare, Basic Information On Tamoxifen Breast Cancer Treatment Viagra exerciseCan you buy viagra in netherlandsHow can i buy cialis online Tamoxifen is a selective oestrogen-receptor modulator indicated for palliative and adjuvant treatment of oestrogen-receptor-positive breast cancer in premenopausal and postmenopausal women. Tamoxifen for breast cancer - GOV. UK. Ten Years of Tamoxifen Reduces Breast Cancer Recurrences.. Тамоксифен - Breast-Cancer. Ru. Dec. 14, 2007 San Antonio -- Even after treatment ends, Arimidex beats out tamoxifen in preventing breast cancer recurrence in women with hormone-fueled. Breast cancer treatments are done and I am considered Cancer Free. Post-treatments, women with hormonal cancers usually have to take Tamoxifen and get annual Mammograms! There is a myth in the conventional medical community that says that the natural hormones in a woman’s body cause breast cancer. This couldn’t be.